261 related articles for article (PubMed ID: 9051760)
1. Huperzine A, a novel promising acetylcholinesterase inhibitor.
Cheng DH; Ren H; Tang XC
Neuroreport; 1996 Dec; 8(1):97-101. PubMed ID: 9051760
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
Cheng DH; Tang XC
Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220
[TBL] [Abstract][Full Text] [Related]
3. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.
Wang T; Tang XC
Eur J Pharmacol; 1998 May; 349(2-3):137-42. PubMed ID: 9671090
[TBL] [Abstract][Full Text] [Related]
4. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
5. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
Zhao Q; Tang XC
Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575
[TBL] [Abstract][Full Text] [Related]
6. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats.
Xiong ZQ; Tang XC
Pharmacol Biochem Behav; 1995; 51(2-3):415-9. PubMed ID: 7667362
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
8. Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.
Rupniak NM; Tye SJ; Field MJ
Psychopharmacology (Berl); 1997 Jun; 131(4):406-10. PubMed ID: 9226744
[TBL] [Abstract][Full Text] [Related]
9. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
Chen H; Xiang S; Huang L; Lin J; Hu S; Mak SH; Wang C; Wang Q; Cui W; Han Y
Metab Brain Dis; 2018 Aug; 33(4):1131-1139. PubMed ID: 29564727
[TBL] [Abstract][Full Text] [Related]
10. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M
Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986
[TBL] [Abstract][Full Text] [Related]
11. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891
[TBL] [Abstract][Full Text] [Related]
12. Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance.
Liu J; Zhang HY; Tang XC; Wang B; He XC; Bai DL
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):413-6. PubMed ID: 10375798
[TBL] [Abstract][Full Text] [Related]
13. Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia.
Kojima J; Nakajima K; Ochiai M; Nakayama K
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):245-51. PubMed ID: 9228650
[TBL] [Abstract][Full Text] [Related]
14. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
[TBL] [Abstract][Full Text] [Related]
15. Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147.
Chen Z; Xu AJ; Li R; Wei EQ
Acta Pharmacol Sin; 2002 Apr; 23(4):355-60. PubMed ID: 11931694
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
17. Effect of rivastigmine on scopolamine-induced memory impairment in rats.
Bejar C; Wang RH; Weinstock M
Eur J Pharmacol; 1999 Nov; 383(3):231-40. PubMed ID: 10594314
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268).
Braida D; Paladini E; Griffini P; Lamperti M; Colibretti L; Sala M
Pharmacol Biochem Behav; 1998 Apr; 59(4):897-901. PubMed ID: 9586846
[TBL] [Abstract][Full Text] [Related]
19. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
Ye JW; Cai JX; Wang LM; Tang XC
J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
[TBL] [Abstract][Full Text] [Related]
20. Huperzine A ameliorates the spatial working memory impairments induced by AF64A.
Zhi QX; Yi FH; XI CT
Neuroreport; 1995 Nov; 6(16):2221-4. PubMed ID: 8595207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
